印地安那州因胰岛素价格上涨起诉Eli Lilly, Indiana sues Eli Lilly over insulin price hikes, alleging collusion and harm to patients and state programs.

印第安纳州总检察长Todd Rokita起诉Eli Lilly, 指称该公司与其他胰岛素制造商和药店福利经理合谋, 尽管生产成本低, 却不顾国家反托拉斯法和消费者保护法, Indiana Attorney General Todd Rokita has sued Eli Lilly, alleging the company conspired with other insulin makers and pharmacy benefit managers to inflate prices over 1,000% despite low production costs, violating state antitrust and consumer protection laws. 诉讼要求获得禁令和赔偿, 理由是印第安纳州的70万糖尿病患者和州医疗保健计划受到损害. The lawsuit seeks injunctive relief and damages, citing harm to Indiana’s 700,000 diabetics and state healthcare programs. Rokita声称Eli Lilly拒绝了先前的谈话, 而该公司则说它已经削减了价格, 将患者费用限制在每月35美元。 Rokita claims Eli Lilly rejected prior talks, while the company says it has already cut prices and capped patient costs at $35 monthly. 本案与相关的联邦多地区诉讼是分开的。 The case is separate from a related federal multidistrict litigation.